Home

Our Mission

Contact Us 

Disclaimer 

Acne Vulgaris 

Hairloss

Atopic Eczema

Psoriasis

Skinaging

Skin A to Z

STD Centre
 

 

Main Branch 
#09-06 Gleneagles Med Ctr 6 Napier Rd
Singapore 258499
Tel: (65) 64710965
Fax: (65) 64721984

Operating Hours: 
9am - 5pm (Mon - Fri)
9am-1pm (Sat)
Strictly by appointment 

 

 

Credits 
Photos:
Surgery photo courtesy of National Cancer Institute, US;
Laser photo courtesy of Coherent Lasers.
 
 

Welcome to MDderma.com
the official website of K B Lim Skin Clinic Pte Ltd, Singapore.
 
Profile of Founder and Consultant Dermatologist, Dr Lim Kah Beng 

Dr Lim completed his high school education in Epsom College, Surrey, England and studied medicine at the Charing Cross Hospital Medical School which is now part of the Imperial College School of Medicine. He obtained his MRCP in 1980 and went on to specialise in Dermatology at the St John's Hospital for Diseases of the Skin (renamed St John's Institute of Dermatology, King's and St Thomas School of Medicine) in London. After working 1-year in the Academic Department of Genitourinary Medicine in James Pringle House, Middlesex Hospital, Dr Lim moved to Singapore and worked in Middle Road Hospital (the predecessor of National Skin Centre) for 6 years. Dr Lim left for private practice in 1988 and is now practising full time as a Dermatologist in Gleneagles Medical Centre, Singapore. He was also Visiting Consultant and then Visiting Specialist in the National Skin Centre for about 3 years. Dr Lim treats all types of medical and cosmetic skin disorders and has a special interest in lasers for the treatment of pigmentary disorders and laser hair removal.

Dr Lim's loves to write and has published numerous research papers in local and international peer reviewed journals as well as several books - Steps to Skin Beauty: A Dermatologist's Guide; Hair Problems: Everyone has them; Safer Sex and No More Pimples: A Self-Care Guide and a novel. 21st Century Slaves is his first novel.

Dr Lim still continues his research and has developed the CSB Fungal stain, which is now routinely used as a fungal stain in large hospital in New South Wales, Australia. He is also interested in the health-promoting effects of anti-oxidants and has developed the Ferric Reducing Capacity (FRC) assay for measuring the total anti-oxidant capacity of serum and food products.

Our Services

  • Laser skin resurfacing to improve sun-damaged skin, wrinkles and scars 
  • Laser treatment of age spots, pigmentation, tattoos, spider veins and birthmarks
  • Laser hair removal
  • Photorejuvenation to improve sun-damaged and aged skin
  • Sclerotherapy treatment of varicose veins
  • Chemical peels using including alpha hydroxy acids (AHA or glycolic acid), betahydroxy acid (BHAs), trichloroacetic acid (TCA)
  • Botox treatment of wrinkles and frown lines 
  • Fillers for wrinkles, scars and contouring  
  • Microdermabrasion treatment of fine lines, pore size and mild scarring
  • Treatment of all skin diseases and STDs  

Skin Care Products 

MD Derma is a range of skin care products specially formulated for the Asian skin. It includes basic skin care products such as Cleansing Gel, Toner and Sunscreen plus Lightening creams and Vitamin C Serum.

MD Derma is the trademark of K B Lim Skin Clinic Pte Ltd

Skin A to Z 

An electronic textbook of Dermatology (Skin Medicine) to provide readers with factual and up-to-date information and useful self-help tips.
Can we delay ageing? 
 

Photo courtesy of Michael Bonkowski

Every cell in our body will age. With wrinkles and age spots, the skin is the first human organ to show signs of ageing. It would be wrong to suggest that we have found a way to beat ageing. The truth is we have not but studies on animals models such as the mouse above are providing insights into the biology of ageing. Some time in the future we may have treatments to delay the ageing process. In the meantime, we do know enough about the ageing process, to formulate strategies that target processes implicated in the ageing process.

Two popular theories on ageing can form the basis of our age defying strategy:

  • The free radical or anti-oxidant theory
  • The hormonal theory  
 
CSB Fungal Stain 
Contrast stain for the office confirmation of superficial fungal infections. Just add to KOH and read. Click on image to learn more.
Click on image to find out more about
the latest Heart-stopping Sci-Fi thriller from Dr Lim Kah Beng
 
Other Books Written by Dr Lim 
Anatomy of the Skin 

Learn about the anatomy (structure) and function of the skin and how it changes with disease and aging.

STD Centre

Information on sexually transmitted diseases (STDs), how they are transmitted, treated and how they can be prevented. To enter, click on the image. 

 
Breaking News 

Tazorac (tazarotene) Gel approved by the USFDA in June 1997 for the treatment of stable plaque psoriasis of up to 20 % of body surface area.

Metrogel (metronidazole) Gel received USFDA approval in November 1998 for the treatment of moderate to severe acne rosacea.

Elidel (pimecrolimus) Cream received USFDA approval in December 2001 for the treatment of mild to moderate atopic dermatitis in patients aged 2 years or more.

Botox Cosmetic (botulinum toxin) was approved by the USFDA in April 2002 for the temporary improvement of moderate to severe glabellar wrinkles in adult men and women, ages 65 and younger.

Finacea (azelaic acid) Gel 15% received USFDA approval in December 2002 for the treatment of mild to moderate acne rosacea. It is also marketed as Skinoren.

Protopic (tacrolimus) Ointment received USFDA approval in December 2002 for the treatment of atopic dermatitis in patients aged 2 years.

Amevive (alefacept) became the first biological therapy to be approved by the USFDA (in January 2003) for the treatment of moderate to severe plaque psoriasis. Alefacept works against psoriasis, in part, by reducing the number of T cells in the body.

Enbrel (etanercept) received USFDA approval in April 2004 for chronic moderate to severe psoriasis. Enbrel inhibits Tumor Necrosis Factor alpha (TNF-alpha), an inflammation-promoting substance produced by activated T cells in patients with psoriasis.

Radiesse (calcium hydroxylapatite microspheres) received USFDA approval in December 2006 for facial aesthetic applications. It stimulates the body to produce new collagen and the improvement is immediate and lasts an average of one year or more.

Remicade (infliximab) received USFDA approval in September 2006 for chronic severe plaque psoriasis. Remicade inhibits Tumor Necrosis Factor alpha (TNF-alpha), an inflammation-promoting substance produced by activated T cells in patients with psoriasis.

Humira (adalimumab) received USFDA approval in January 2008 for treatment of moderate to severe chronic plaque psoriasis. Humira inhibits Tumor Necrosis Factor alpha (TNF-alpha), an inflammation-promoting substance produced by activated T cells in patients with psoriasis.

Raptiva (efalizumab) used for chronic and severe plaque psoriasis was withdrawn from the US market as of June 2009 due to increased risk of PML (progressive multifocal leucoencephalopathy). Raptiva inhibits T cells, the immune cells that congregate in psoriasis plaques and trigger inflammation.

Sculptra®Aesthetic (injectable poly-L-lactic acid) received USFDA approval for for facial aesthetic applications. Sculptra stimulates the body to produce new collagen. The effect is gradual and can last up to two years.

Stelara (ustekinumab) received USFDA approval in September 2009 for the treatment of moderate to severe plaque psoriasis in adults.Stelera blocks the action of two cytokines IL-12 and IL-23, which stimulate type 1 T-helper cell responses and contribute to the overproduction of skin cells and inflammation.